Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature

被引:9
|
作者
John, Alexius [1 ,2 ]
Spain, Lavinia [2 ]
Hamid, Anis A. [1 ,2 ,3 ,4 ]
机构
[1] Eastern Hlth, Dept Med Oncol, Melbourne, Vic 3128, Australia
[2] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic 3000, Australia
[3] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic 3128, Australia
[4] Univ Melbourne, Dept Surg, Melbourne, Vic 3010, Australia
关键词
non-clear cell; renal cell carcinoma; papillary; hereditary leiomyomatosis and renal cell cancer; chromophobe; medullary; collecting duct; COMPREHENSIVE MOLECULAR CHARACTERIZATION; OPEN-LABEL; PHASE-II; SUNITINIB; CABOZANTINIB; EPIDEMIOLOGY; MULTICENTER; MONOTHERAPY; EXPRESSION; CRIZOTINIB;
D O I
10.3390/curroncol30010070
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-clear cell renal cell carcinoma (nccRCC) is an entity comprised of a heterogeneous constellation of RCC subtypes. Genomic profiling has broadened our understanding of molecular pathogenic mechanisms unique to individual nccRCC subtypes. To date, clinical trials evaluating the use of immunotherapies and targeted therapies have predominantly been conducted in patients with clear cell histology. A comprehensive review of the literature has been undertaken in order to describe molecular pathogenic mechanisms pertaining to each nccRCC subtype, and concisely summarise findings from therapeutic trials conducted in the nccRCC space.
引用
下载
收藏
页码:923 / 937
页数:15
相关论文
共 50 条
  • [31] Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
    Koshkin, Vadim S.
    Barata, Pedro C.
    Zhang, Tian
    George, Daniel J.
    Atkins, Michael B.
    Kelly, William J.
    Vogelzang, Nicholas J.
    Pal, Sumanta K.
    Hsu, JoAnn
    Appleman, Leonard J.
    Ornstein, Moshe C.
    Gilligan, Timothy
    Grivas, Petros
    Garcia, Jorge A.
    Rini, Brian I.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [32] Safety and efficacy of sunitinib for advanced non-clear cell renal cell carcinoma
    Shi, Hong-Zhe
    Tian, Jun
    Li, Chang-Ling
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 (04) : 328 - 333
  • [33] Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma
    Han, Seung Hun
    Camp, Sabrina Y.
    Chu, Hoyin
    Collins, Ryan
    Gillani, Riaz
    Park, Jihye
    Bakouny, Ziad
    Ricker, Cora A.
    Reardon, Brendan
    Moore, Nicholas
    Kofman, Eric
    Labaki, Chris
    Braun, David
    Choueiri, Toni K.
    AlDubayan, Saud H.
    Van Allen, Eliezer M.
    EUROPEAN UROLOGY OPEN SCIENCE, 2024, 62 : 107 - 122
  • [34] Does immunoscore have a significant effect on survival for non-clear cell renal cell carcinoma as well as clear cell renal cell carcinoma?
    Selvi, Ismail
    Demirci, Umut
    Bozdogan, Nazan
    Basar, Halil
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (06) : 1135 - 1138
  • [35] Clinical outcomes of checkpoint inhibitors in metastatic non-clear cell renal cell carcinoma and clear cell renal cell carcinoma with variant features.
    Chang, Guy vin
    Ellithi, Moataz
    Elnair, Radowan
    Bleeker, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] Targeted Literature Review of Outcomes to Initial Systemic Therapy for Advanced/Metastatic Non-Clear Cell Renal Cell Carcinoma in Observational Studies
    Calhoun, Shawna R.
    Sharma, Manish
    Lee, Chung-Han
    KIDNEY CANCER, 2023, 7 (01) : 123 - 136
  • [37] Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma
    Cotta, Brittney H.
    Choueiri, Toni K.
    Cieslik, Marcin
    Ghatalia, Pooja
    Mehra, Rohit
    Morgan, Todd M.
    Palapattu, Ganesh S.
    Shuch, Brian
    Vaishampayan, Ulka
    Van Allen, Eliezer
    Hakimi, Ari
    Salami, Simpa S.
    EUROPEAN UROLOGY, 2023, 84 (02) : 166 - 175
  • [38] Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula
    Kopp, Ryan P.
    Aganovic, Lejla
    Palazzi, Kerrin L.
    Cassidy, Fiona H.
    Sakamoto, Kyoko
    Derweesh, Ithaar H.
    CANADIAN JOURNAL OF UROLOGY, 2013, 20 (03) : 6790 - 6797
  • [39] Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
    Lee, Jii Bum
    Park, Hyung Soon
    Park, Sejung
    Lee, Hyo Jin
    Kwon, Kyung A.
    Choi, Young Jin
    Kim, Yu Jung
    Nam, Chung Mo
    Cho, Nam Hoon
    Kang, Beodeul
    Chung, Hyun Cheol
    Rha, Sun Young
    CANCER RESEARCH AND TREATMENT, 2019, 51 (04): : 1578 - 1588
  • [40] DOES CYTOREDUCTIVE NEPHRECTOMY IMPROVE SURVIVAL IN NON-CLEAR CELL RENAL CELL CARCINOMA?
    Kenney, Patrick
    Chapin, Brian
    Culp, Stephen
    Richey, Stephen
    Nogueras-Gonzalez, Graciela
    Tamboli, Pheroze
    Tannir, Nizar
    Wood, Christopher
    JOURNAL OF UROLOGY, 2012, 187 (04): : E727 - E727